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Abstract  
 
The objective of the current study was to develop a simple, precise, rapid and accurate reverse phase 
liquid chromatographic method for the quantitative determination on furazolidone, oxytetracycline and 
related substances in veterinary formulation. This formulation was submitted to accelerated degradation 
studies under acidic, alkaline and oxidative conditions, exposure to light and thermal stability. The 
separation of furazolidone, oxytetracycline and degradation products was achieved on BDS Hypersil C18 
(250mmx4.6mm, i.d. 5 µm particle size) with gradient mobile phase containing methanol and 80 mM 
dipotassium phosphate pH 7,5 (20/80). The flow rate was 1.0 mL/min and detection was set at 254 nm, at 
25 
0C. The developed method was validated with respect to linearity, limits of detection and 
quantification, specificity, accuracy, and precision. 
 
Rezumat 
 
Obiectivul acestui studiu a fost dezvoltarea unei metode simple, precise, rapide úi exacte de determinare 
a furazolidonei, oxitetraciclinei úi substanĠelor înrudite din produsele farmaceutice veterinare. Produsul 
farmaceutic a fost supus degradarii accelerate in urmatoarele medii: acid, basic, oxidant, degradare 
temica úi în prezenta luminii. Metoda de separare simultană a furazolidonei úi oxitetraciclinei a fost 
realizată pe o colonă Hypersil BDS RP-C18, (250mmx4.6mm, i.d. 5 µm diametrul particulei) folosind drept 
fază mobilă amestecul metanol - fosfat de potasiu dibasic 80 mM pH 7,5 (20/80). Gradientul folosit pentru 
elutie este prezentat in tabelul 1. Debitul de 1 mL/min úi lungimea de unda de 254 au fost folosite în 
validarea metodei urmărind parametrii: liniaritate, limită de detecĠie úi cuantificare, specificitatea, 
acuratete úi precizie. 
 
Oxytetracycline is a broad-spectrum 
antibiotic that is commonly used in veterinary 
medicine as inhibits the protein synthesis in 
gram-positive and gram-negative bacteria.  
The European community has approved 
the use of oxytetracycline in a wide range of 
animal species like cattle, sheep, goats and 
pigs. 
However,  oxytetracycline  and 
oxytetracycline hydrochloride may contain 
several impurities that should not exceed 
certain levels in the raw material according to 
European Pharmacopoeia. 
Furazolidone is a veterinary drug that 
belong to the family of nitrofuran antibacterial 
compounds, with a molecular structure 
characterised by the presence of a 5-nitro 
group.  
This group has a broad antibacterial and 
antiparasitic activity and for this reason, 
nitrofurans are widely used as veterinary 
drugs, mainly for the treatment of 
gastrointestinal infections in cageling, cats 
and dogs. 
The purpose of the novel HPLC method 
is to develop simultaneous estimation of Violeta Giugiu                                                                                                                      Medicamentul Veterinar / Veterinary Drug 
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furazolidone, oxytetracycline, and related 
substances in veterinary formulation with 
good precision, accuracy, linearity and short 
time for analysis. 
 
1. Materials and methods 
 
1.1. Chemicals, reagents and standards 
 
The  standards of furazolidone,  was 
purchased from USP.  
The  standards of oxytetracycline, 4-
epioxytetracycline,  Į-apooxytetracycline, 
tetracycline,  ȕ-apooxytetracycline  were 
purchased from European Pharmacopoeia.  
Veterinary  formulation,  Oxifuran 
Vitaminizat, analyzed in this study was 
purchased from Romvac Company. 
High purity water used in analytical 
procedures was obtained from Millipore Milli-
Q system. Methanol of HPLC grade was 
purchased  from  Merck,  dipotassium 
phosphate and hydrochloric acid were 
obtained from Fluka. Ortho-phosphoric acid 
85%, used for pH adjustment, was 
purchased  from  Merck.  N,N-
dimethylforamide  used  for  samples 
extraction was supplied by Sigma Aldrich. 
 
1.2.Apparatus and chromatographic 
conditions 
 
Analysis were carried out on HPLC –
DAD model LC Surveyor system (Thermo 
Electron Corporation, USA) equipped with a 
quadrennial pump, an auto sampler, an 25 
µL loop, column thermostat, auto sampler 
thermostat and DAD detector. Integration 
was achieved by using ChromQuest 
software.  
A Hypersil BDS RP-C18 column (250 mm 
x 4.6 mm x 5 µm particle size) was used for 
this analysis and the mobile phase consist of 
methanol and 80 mM dipotassium phosphate 
pH 7,5. The flow rate of the mobile phase 
was 1.0 mL/min.  
The  optimized gradient  elution 
programme is given in the table 1.  
A wavelength of 254 nm was found to be 
suitable for this analysis and the column 
temperature was maintained at 25
0C.The 
injection volume was 10 µL.Table 1 
 
Table 1 
The optimized gradient elution program for 
separation 
 
Time 
(min) 
% solvent B 
HK2PO4 
%solvent C 
methanol 
0.00  80.00  20.00 
5.00  60.00  40.00 
15.00  60.00  40.00 
20.00  80.00  20.00 
30.00  80.00  20.00 
 
1.3. Preparation of standard solution 
 
A stock solution of furazolidone (0.32 
mg/mL) was prepared by dissolving an 
appropiate amount of standard in DMF. 
A stock solution of oxytetracycline (1 
mg/mL) was prepared by dissolving an 
appropiate amount of standard in 0,01M HCl.  
Stock solution of 4-epioxytetracycline (1 
mg/mL), tetracycline hydrocloride (1 mg/mL), 
Į-apooxytetracycline (0,12 mg/mL), ȕ-
apooxytetracycline  (0,12  mg/mL)  were 
prepared by dissolving separately an 
appropiate amount of each impurities in 0,01 
M HCl. Stock standard solution were stored 
at cooler. 
 
1.4.Preparation of sample solution 
 
Sample (0.286 g Oxifuran Vitaminizat – 
dust) equivalent to 40 mg of oxytetracycline 
and 11.44 mg of furazolidone was 
transferred into a 50 mL volumetric flask. 
Add about 15 mL of 0.01M HCl and 16 mL of 
DMF and sonicate to dissolve it completely 
and make volume up to the mark with 0.01M 
HCl. Mix well and filter through quantitative 
filter paper.  
A volume of 0.32 mL was quantitatively 
transferred to a 5 mL volumetric flask and the 
volume was completed with 0.01M HCl. 
Before injection in the chromatographic 
system, the solution was filtred trough 0.45 
µm PVDF filter. 
 
1.5.Method validation 
 
This method was validated by sress 
studies, linearity, limits of detection and 
quantification, precision and acuracy. Violeta Giugiu                                                                                                                      Medicamentul Veterinar / Veterinary Drug 
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1.5.1. Forced degradation studies 
Stressed  degradation  studies  were 
performed to evaluate the specificity of the 
method. The specificity of the developed 
method was determined in the presence of 
impurities and degradation products.  
The stress condition employed for the 
degradation study included light (Vision 30W, 
UV-C, 253nm), heat ( 60
0C), acid hydrolysis 
(0.1 M HCl), base hydrolysis (0.1 NaOH) and 
oxidation (3% H2O2).  
For acid hydrolysis, base hydrolysis and 
oxidation, the samples were exposed for 90 
minutes at 25 
0C.  
Thermal degradation studies were performed 
at  60 
0C for 1 h. In photo-degradation 
studies, the drug sample was exposed to 
light for 24 h. 
 
1.5.2. Linearity 
In order to study linearity of the respons, 
a series of five concentration levels from 
10%-200% of assay analytes concentrations 
were prepared from stock solutions.  
The linearity performed above, was used 
for the  determination  of  limits of 
quantification and detection. 
 
1.5.3. Precision and accuracy 
The precision of the proposed method 
was evaluated by performing six independent 
assays of the Oxifuran Vitaminizat test 
sample.  
The accuracy of the assay method was 
tested by analyzing the recovery of 
furazolidone and oxytetracycline in triplicat in 
three concentrations from 80%-120%.  
 
2. Results and discussion 
 
The goal of this study was to design a 
HPLC method that allows separation of 
furazolidone,  oxytetracycline,  4-epi 
oxytetracycline,  Į-apooxytetracycline, 
tetracycline, ȕ-apooxytetracycline.  
The best separation was achived on a 
Hypersil BDS C18 column (250 mm x 4,6 mm 
x 5 µm), with methanol - 80 mM dipotassium 
phosphate pH 7,5 (20/80 v/v) in gradient 
elution.  
The system suitability parameters were 
evaluated from standard chromatograms (fig. 
1). Resolution (R), asymmetry, retention 
time, theoretical plates and capacity factor, 
calculated automatically using the software, 
are in table 2. 
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Figure 1. Chromatogram of the solution containing furazolidone, 4-epioxytetracycline, oxytetracycline,  
Į-apooxytetracycline, tetracycline, ȕ-apooxytetracycline Violeta Giugiu                                                                                                                      Medicamentul Veterinar / Veterinary Drug 
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Table 2 
Separation data calculated for components presented in figure 1 
 
Name  Retention 
Time 
Resolution  
EP 
Asymmetry  Plates /  
meter 
Capacity  
factor 
furazolidone  7.295  21.09044  1.17  13939.99  13.59000 
4 epioxytetracycline  7.988  -6.20175  1.56  7735.06  14.97667 
oxytetracycline  9.398  0.00000  1.25  11053.98  17.79667 
Į-apooxytetracycline  13.033  13.53220  1.12  11130.45  25.06667 
tetracicline  14.183  12.13161  0.89  4035.81  27.36667 
ȕ-apooxytetracycline  16.285  8.04226  1.49  6836.26  31.57000 
 
Forced degradation studies of Oxifuran 
Vitaminizat were carried out under various 
stress  conditions  and  the  resultant 
chromatograms are shown in Fig. 2a-2e.  
The proposed method can be useful for 
quantitative determination of furazolidone 
and oxytetracycline under different stress 
conditions. 
The mobile phase proposed was found 
to be appropriate for the adequate separation 
of furazolidone (tR= 7.2 min), oxytetracycline 
(tR= 9.3 min), in presence of related 
substances at a flow rate of 1.0 mL/min. UV 
detection wavelength at 254 nm, injection 
volum 10 ȝL, ambient temperature for 
column and HPLC system was found to be 
best for analysis. Forced degradation study 
of Oxifuran Vitaminizat was carried out under 
acidic, alkaline, oxidative, thermal and 
photolitic conditions. The values achieved in 
conditions used for forced degradation, are 
shown in table 3 -4. 
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Figure 2. Chromatograms of Mibarom samples in different stress conditions (a) acid , (b) base, (c) oxidation, (d) 
UV radiations, (e) thermal degradation 
c 
d  d 
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Table 3. 
Degradation of furazolidone in Oxifuran Vitaminizat product 
 
Degaradion 
parameter 
Degradation 
time  Result of degradation 
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vitaminizat  10 min  -  2667425  100  0  7.4  1.18  14379.24 
PD HCl 0.1 N  90 min  2452178  2667425  91.93  8  7.4  1.18  14281.91 
PD NaOH 0.1N 90 min  0  2667425  0.00  100  0.0  0.00  0 
PD H2O2 3%  90 min  2636062  2667425  98.82  1  7.5  1.17  14452.09 
PD terminc  60 min  2478007  2667425  92.90  7  7.5  1.18  14186.18 
PD UV 24h  24 h  1896760  2667425  71.11  29  7.3  1.18  14347.38 
 
Table 4. 
Degradation of oxytetracycline in Oxifuran Vitaminizat product 
 
Degaradion 
parameter 
Degradation 
time  Result of degradation 
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PD HCl 0.1 N  90 min  4753817  4759968  99.87  0  9.5  1.18  11711.71 
PD NaOH 0.1 N  90 min  4645805  4759968  97.60  2  9.6  0.00  11632.01 
PD H2O2 3%  90 min  4663116  4759968  97.97  2  9.6  1.17  11583.75 
PD terminc  60 min  4580245  4759968  96.22  4  9.7  1.18  11874.39 
PD UV 24h  24 h  2733119  4759968  57.42  43  9.4  1.18  11640.43 
The linear calibration plot for the assay 
method was obtained over the tested 
calibration  range  (0.0014-0.028  mg/mL 
furazolidone,  0,005-0,1mg/mL 
oxytetracycline) and the obtained correlation 
coefficient was greater the 0,999. 
The results indicated an excellent 
correlation between the peaks area and 
concentration of the analytes. 
Based on the linearity curve, performed 
above, the quantification and detection limits 
were calculated.  
The detection limit found was:  
x 0,029 µg/mL furazolidone and  
x 0,086 µg/mL oxytetracycline,  
and quantification limit was:  
x 0,097 µg/mL furazolidone and  
x 0,286 µg/mL oxytetracycline.  
The precision of the method was 
determined in terms of repetability (intraday) 
and intermediate (interday) precision.  
The intraday and interday variation in the 
peak area of drug solution was calculated in 
terms of % RSD.  
The % RSD was found to be within the 
specified limits (not more than 2).  
The precision data is presented in table 
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Table 5. 
Results of method precision measurement 
 
Substance  Furazolidone (g%)  Oxytetracycline (g%) 
Sample  Intraday 
repeatability 
Intraday 
repeatability 
Intraday 
repeatability 
Intraday 
repeatability 
1   3.879  3.934  13.324  13.642 
2   3.874  3.897  13.369  13.567 
3   3.881  3.924  13.479  13.668 
4   3.858  3.892  13.429  13.564 
5   3.862  3.916  13.465  13.674 
6   3.867  3.879  13.548  13.548 
Mean  3.870  3.907  13.436  13.611 
RSD%  0.247  0.537  0.599  0.419 
 
Accuracy expressed as a percentage of 
recovered drug substance was determined 
by  comparing  calculated  values  of 
concertation  of  furazolidone  and 
oxytetracycline in samples with expected 
values. The average drug recovery obtained 
in the concentration range from 80%-120% 
was 99.59% for furazolidone and 99.87% for 
oxytetracycline (table 6).  
 
Table 6. 
Results of method accuracy measurement 
 
Active 
substance 
Theoretical 
concentration(g%) 
Concentaration 
found* (g%) 
Recovery 
percentage(%)* 
Average 
recovery(%) 
furazolidone 
3.2  3.1746  99.2 
99.59  4  4.036  100.9 
4.8  4.7366  98.68 
oxytetracycline 
11.2  11.04  98.25 
99.8791  14  14.21  101.5024 
16.8  16.78  99.88492 
 
Conclusions 
 
The development of HPLC methods for 
the determination of drugs has great 
attention in analytical research because of 
their importance in quality control. In 
analytical research, the time and cost of 
method development and validation are of 
great importance. The objective of this study 
was to develop and validated a simple, rapid, 
economic and accurate HPLC method for the 
estimation  of  furazolidone  and 
oxytetracycline in veterinary formulation. 
Examination of results shows a good 
correlation between the retention time of 
furazolidone and oxytetracycline standard 
and Oxifuran Vitaminizat sample.  
Force degradation studies confirmed its 
ability to determine stability because no 
interference from degradation products was 
observed. It can be concluded that the 
developed  method  could  separate 
furazolidone  and  oxytetracycline  from 
degradation products. 
Statistical analysis proved that, the 
method developed was accurate, precise 
and repeatable for determination of limits of  
impurities, quantification of oxytetracycline 
and furazolidone in Oxifuran Vitaminizat. 
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